$3.25 Billion is the total value of Camber Capital Management LP's 39 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 44.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $200,637,000 | +76.8% | 1,450,000 | +87.1% | 6.18% | +61.6% |
| WBA | Buy | WALGREENS BOOTS ALLIANCE INC | $188,200,000 | +2.2% | 4,000,000 | +14.3% | 5.80% | -6.6% |
| THC | Sell | TENET HEALTHCARE CORP | $182,710,000 | -4.3% | 2,750,000 | -3.5% | 5.63% | -12.5% |
| NVS | New | NOVARTIS AGcall | $163,560,000 | – | 2,000,000 | +100.0% | 5.04% | – |
| VTRS | VIATRIS INC | $162,600,000 | -5.2% | 12,000,000 | 0.0% | 5.01% | -13.3% | |
| MRK | MERCK & CO INCcall | $150,220,000 | -3.4% | 2,000,000 | 0.0% | 4.63% | -11.7% | |
| SNY | Buy | SANOFIsponsored adr | $144,630,000 | +22.1% | 3,000,000 | +33.3% | 4.45% | +11.6% |
| PRGO | PERRIGO CO PLC | $118,325,000 | +3.2% | 2,500,000 | 0.0% | 3.64% | -5.6% | |
| MRK | MERCK & CO INC | $112,665,000 | -3.4% | 1,500,000 | 0.0% | 3.47% | -11.7% | |
| HCA | Sell | HCA HEALTHCARE INC | $108,617,000 | -12.4% | 447,500 | -25.4% | 3.34% | -20.0% |
| ZBH | New | ZIMMER BIOMET HOLDINGS INC | $106,124,000 | – | 725,090 | +100.0% | 3.27% | – |
| GSK | GLAXOSMITHKLINE PLCsponsored adr | $105,078,000 | -4.0% | 2,750,000 | 0.0% | 3.24% | -12.3% | |
| GILD | Buy | GILEAD SCIENCES INCcall | $104,775,000 | +52.2% | 1,500,000 | +50.0% | 3.23% | +39.1% |
| BKD | Buy | BROOKDALE SR LIVING INC | $100,800,000 | -16.9% | 16,000,000 | +4.2% | 3.10% | -24.0% |
| AZN | Sell | ASTRAZENECA PLCcall | $90,090,000 | -24.8% | 1,500,000 | -25.0% | 2.77% | -31.3% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $88,884,000 | – | 1,150,000 | +100.0% | 2.74% | – |
| MYGN | Sell | MYRIAD GENETICS INC | $88,798,000 | -3.2% | 2,750,000 | -8.3% | 2.73% | -11.5% |
| ALKS | Sell | ALKERMES PLC | $84,039,000 | -20.3% | 2,725,000 | -36.6% | 2.59% | -27.1% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $83,850,000 | +5.1% | 2,500,000 | +25.0% | 2.58% | -3.9% |
| CHNG | Buy | CHANGE HEALTHCARE INC | $83,760,000 | +54.7% | 4,000,000 | +70.2% | 2.58% | +41.4% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $79,610,000 | +23.2% | 450,000 | +12.5% | 2.45% | +12.6% |
| GILD | Sell | GILEAD SCIENCES INC | $76,835,000 | -20.3% | 1,100,000 | -21.4% | 2.37% | -27.2% |
| IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $71,830,000 | -25.6% | 5,500,000 | -26.7% | 2.21% | -32.0% |
| RETA | Buy | REATA PHARMACEUTICALS INCcl a | $68,918,000 | +4.7% | 685,000 | +47.3% | 2.12% | -4.3% |
| NKTR | Buy | NEKTAR THERAPEUTICS | $67,350,000 | +12.1% | 3,750,000 | +7.1% | 2.07% | +2.5% |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $48,700,000 | -10.6% | 5,000,000 | -9.1% | 1.50% | -18.3% |
| SNY | New | SANOFIcall | $48,210,000 | – | 1,000,000 | +100.0% | 1.48% | – |
| OSUR | Buy | ORASURE TECHNOLOGIES INC | $48,068,000 | +32.6% | 4,250,000 | +18.9% | 1.48% | +21.2% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $46,240,000 | – | 500,000 | +100.0% | 1.42% | – |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $39,480,000 | -16.5% | 2,000,000 | 0.0% | 1.22% | -23.7% | |
| PTCT | New | PTC THERAPEUTICS INC | $27,908,000 | – | 750,000 | +100.0% | 0.86% | – |
| IRTC | New | IRHYTHM TECHNOLOGIES INC | $27,816,000 | – | 475,000 | +100.0% | 0.86% | – |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $24,009,000 | -4.0% | 3,425,000 | +25.7% | 0.74% | -12.3% |
| ZYME | New | ZYMEWORKS INC | $21,780,000 | – | 750,000 | +100.0% | 0.67% | – |
| BIIB | New | BIOGEN INC | $21,224,000 | – | 75,000 | +100.0% | 0.65% | – |
| RDUS | RADIUS HEALTH INC | $18,615,000 | -32.0% | 1,500,000 | 0.0% | 0.57% | -37.9% | |
| TBPH | New | THERAVANCE BIOPHARMA INC | $18,500,000 | – | 2,500,000 | +100.0% | 0.57% | – |
| AVRO | AVROBIO INC | $17,484,000 | -37.2% | 3,133,333 | 0.0% | 0.54% | -42.7% | |
| INNV | Sell | INNOVAGE HLDG CORP | $6,610,000 | -75.2% | 1,000,000 | -20.2% | 0.20% | -77.3% |
| TBIO | Exit | TRANSLATE BIO INC | $0 | – | -1,400,000 | -100.0% | -1.30% | – |
| HOLX | Exit | HOLOGIC INC | $0 | – | -665,000 | -100.0% | -1.50% | – |
| SKIN | Exit | THE BEAUTY HEALTH COMPANY | $0 | – | -4,000,000 | -100.0% | -2.26% | – |
| CAH | Exit | CARDINAL HEALTH INC | $0 | – | -1,250,000 | -100.0% | -2.40% | – |
| PFE | Exit | PFIZER INCcall | $0 | – | -2,000,000 | -100.0% | -2.64% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICALS INDS LTD | 34 | Q3 2023 | 9.7% |
| BROOKDALE SR LIVING INC | 32 | Q3 2023 | 5.0% |
| PERRIGO CO PLC | 29 | Q3 2023 | 7.1% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 8.5% |
| NEKTAR THERAPEUTICS | 28 | Q1 2022 | 9.8% |
| UNIVERSAL HLTH SVCS INC | 25 | Q3 2023 | 9.9% |
| MYRIAD GENETICS INC | 24 | Q3 2023 | 5.0% |
| SAREPTA THERAPEUTICS INC | 23 | Q3 2023 | 6.0% |
| MYLAN NV | 21 | Q3 2020 | 10.1% |
| AMAG PHARMACEUTICALS INC | 21 | Q3 2020 | 4.0% |
View Camber Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC | February 02, 2023 | ? | ? |
| Solid Biosciences Inc. | December 12, 2022 | ? | ? |
| AVROBIO, Inc. | February 14, 2022 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2022 | ? | ? |
| AMAG PHARMACEUTICALS, INC. | February 16, 2021 | ? | ? |
| Atara Biotherapeutics, Inc. | February 16, 2021 | ? | ? |
| Change Healthcare Inc. | February 16, 2021 | ? | ? |
| GLYCOMIMETICS INC | February 16, 2021 | ? | ? |
| Clovis Oncology, Inc. | February 14, 2020 | ? | ? |
| Cyclerion Therapeutics, Inc. | February 14, 2020 | ? | ? |
View Camber Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-30 |
| 13F-HR | 2023-08-14 |
View Camber Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.